Tuesday, September 28, 2021

Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia

New research shows why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and demonstrates a way to restore their effectiveness.

from Top Health News -- ScienceDaily https://ift.tt/3CRiklD
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists reveal the real benefits and hidden risks of medical cannabis

A sweeping review of more than 2,500 studies reveals that despite booming public enthusiasm, cannabis has strong scientific support for only...